Integration of Continuous Renal Replacement Therapy in a Meropenem Population Pharmacokinetics Model in Critically Ill Children

Antimicrob Agents Chemother. 2021 Mar 18;65(4):e02542-20. doi: 10.1128/AAC.02542-20. Print 2021 Mar 18.

Authors

Agathe Béranger¹, Naïm Bouazza², Mehdi Oualha^{2

3}

Affiliations

¹ EA723, Évaluation des thérapeutiques et pharmacologie périnatale et pédiatrique, Paris, France agathe.beranger@gmail.com.
² EA723, Évaluation des thérapeutiques et pharmacologie périnatale et pédiatrique, Paris, France.
³ Réanimation et surveillance continue médico-chirurgicales pédiatriques, AP-HP, Hôpital Necker enfants maladies, Paris, France.

No abstract available

Keywords: pediatric drug therapy; population pharmacokinetics.

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents / therapeutic use
Child
Continuous Renal Replacement Therapy*
Critical Illness
Humans
Meropenem / therapeutic use
Thienamycins / therapeutic use

Substances

Anti-Bacterial Agents
Thienamycins
Meropenem